Correction: PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Age and sex affect deep learning prediction of cardiometabolic risk factors from retinal images.Scientific reports · 2020
   Article
2. Temporal Trends of the Incidence of Ischemic Heart Disease in Iran Over 15 Years: A Comprehensive Report from a Multi-Centric Hospital-Based Registry.Clinical epidemiology · 2020
   Article
3. Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2019
   Article

Corrections and comments

• Erratum for
  PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.2017

Authors and funding

11 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract